Bioventus (BVS) Capital Expenditures Growth (1y) (2021 - 2026)
Powered by 
Analysis
Bioventus (BVS) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -6.52% |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | 40.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 40.56% |
| Mar 28, 2026 | -30.51% |
| Dec 31, 2025 | 1.05% |
| Sep 27, 2025 | 639.06% |
| Jun 28, 2025 | 787.01% |
| Mar 29, 2025 | 183.85% |
| Dec 31, 2024 | 55.56% |
| Sep 28, 2024 | -96.86% |
| Jun 29, 2024 | -94.49% |
| Mar 30, 2024 | -91.83% |
| Dec 31, 2023 | 107.15% |
| Sep 30, 2023 | 23.47% |
| Jul 1, 2023 | -31.18% |
| Apr 1, 2023 | 20.27% |
| Dec 31, 2022 | -157.65% |
| Oct 1, 2022 | -14.38% |
| Jul 2, 2022 | 59.59% |
| Apr 2, 2022 | 116.06% |
| Dec 31, 2021 | -37.17% |
| Oct 2, 2021 | 50.35% |